Skip to main content
OpenTrials

Clinical trial condition

Immune System Diseases

Explore clinical trials studying Immune System Diseases. Study availability and eligibility vary by location and protocol.

35,780 public trials 5,051 recruiting studies
Refine in advanced search Browse all conditions

Immune System Diseases trial results

Recruiting

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

NCT05714839

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • GSK Investigational Site Bullhead City, Arizona, United States
  • GSK Investigational Site Pembroke Pines, Florida, United States
  • GSK Investigational Site Grand Rapids, Michigan, United States
  • GSK Investigational Site Chapel Hill, North Carolina, United States
View all 44 locations
View Trial Details
Recruiting

Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

NCT02140255

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • 4601, University of California, San Diego Clinical Research Site La Jolla, California, United States
  • 5048, University of Southern California Clinical Research Site Los Angeles, California, United States
  • 5112, David Geffen School of Medicine at UCLA Clinical Research Site Los Angeles, California, United States
  • 5052, University of Colorado, Denver Clinical Research Site Aurora, Colorado, United States
View all 46 locations
View Trial Details
Recruiting

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

NCT06947993

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Fort Smith, Arkansas, United States
  • Novartis Investigative Site Fountain Valley, California, United States
View all 105 locations
View Trial Details
Recruiting

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma

NCT05222529

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Novartis Investigative Site Rousse, Bulgaria
  • Novartis Investigative Site Sevlievo, Bulgaria
  • Novartis Investigative Site Sofia, Bulgaria
  • Novartis Investigative Site Ibague, Tolima Department, Colombia
View all 23 locations
View Trial Details
Recruiting

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

NCT06549595

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Research Site Huntsville, Alabama, United States
  • Research Site Anchorage, Alaska, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Clovis, California, United States
View all 228 locations
View Trial Details
Recruiting

To Evaluate the Efficacy and Safety of SG301 SC Injection in Systemic Lupus Erythematosus

NCT07447986

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • China-Japan Friendship Hospital Beijing, Beijing Municipality, China
  • The Second Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • Xiamen University Affiliated Zhongshan Hospital Xiamen, Fujian, China
View all 41 locations
View Trial Details
Recruiting

Elranatamab in Patients With Relapsed or Refractory AL Amyloidosis

NCT06569147

Conditions
AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Yale University New Haven, Connecticut, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Tufts Medical Center Boston, Massachusetts, United States
View Trial Details

Related conditions